Costs associated with adverse events for systemic therapies in metastatic melanoma.

CONCLUSION: The costs of AEs associated with systemic therapies for MM are substantial. PMID: 30192155 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research